For the quarter ending 2026-03-31, VXRT made $39,227,000 in revenue. $5,175,000 in net income. Net profit margin of 13.19%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 39,227,000 | 104,239,000 | 72,413,000 | 39,730,000 |
| Research and development | 29,413,000 | 45,150,000 | 75,947,000 | 49,735,000 |
| General and administrative | 4,641,000 | 3,666,000 | 4,277,000 | 4,598,000 |
| Total operating expenses | 34,054,000 | 48,816,000 | 80,224,000 | 54,333,000 |
| Operating income (loss) | 5,173,000 | 55,423,000 | -7,811,000 | -14,603,000 |
| Interest income | 551,000 | 547,000 | 302,000 | 310,000 |
| Non-cash interest expense related to sale of future royalties | 505,000 | 546,000 | 608,000 | 672,000 |
| Other expense, net | -11,000 | -35,000 | -7,000 | -1,000 |
| Income (loss) before income taxes | 5,208,000 | 55,389,000 | -8,124,000 | -14,966,000 |
| Provision for income taxes | 29,000 | 344,000 | 17,000 | 20,000 |
| Net income (loss) | 5,179,000 | 55,045,000 | -8,141,000 | -14,986,000 |
| Unrealized loss on available-for-sale investments, net of tax | -4,000 | -1,000 | 5,000 | 0 |
| Comprehensive income (loss) | 5,175,000 | 55,044,000 | -8,136,000 | -14,986,000 |
| Basic EPS | 0.02 | 0.233 | -0.04 | -0.07 |
| Diluted EPS | 0.02 | 0.239 | - | - |
| Basic Average Shares | 240,649,773 | 235,860,632 | 228,926,340 | 228,367,812 |
| Diluted Average Shares | 242,184,524 | 230,346,201 | - | - |
Vaxart, Inc. (VXRT)
Vaxart, Inc. (VXRT)